Skip to content

Meet us at COP31Read more

Abera Bioscience AB Sustainability Reports

Abera Bioscience AB is a biotechnology company focused on developing novel mucosal vaccines based on its proprietary vaccine platform technologies. The company designs vaccines for oral and nasal administration targeting seasonal, bacterial, and emerging pandemic pathogens.

Sector: Professional & technical services

Country: Sweden

Exchange: Nordic Growth Market

LEI: 549300IO3Q8IE2FDUS29

FIGI: BBG00YYC16B4

4 reports from 2022 to 2025